(Q45877764)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Bril WS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

MacLean PE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kaijen PH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

van den Brink EN

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lardy NM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Fijnvandraat K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Peters M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

509-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15357778%20AND%20SRC:MED&resulttype=core&format=json

The hemophilias--from royal genes to gene therapy

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01011.X

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01011.X

Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01011.X

CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01011.X